Skip to content
Disclosery

Artia Global Partners LP

Follow

13F filer, CIK 1937964, MIAMI, FL

Artia Global Partners LP reported $705,757,478 across 55 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 72.36% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001937964-26-000002

Period
2025-12-31
Reported value
$706M
Holdings
55
Top 10 weight
72.36%
New
24
Sold out
20

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ABVXadded+375,294$50.6M
LLYadded+21,800$23.4M
VKTXadded+573,186$20.2M
CDTXnew+70,824$15.6M
NAMSadded+309,098$10.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VERONA PHARMA PLCexited-379,004-$40.4M
MERUS N Vexited-296,750-$27.9M
VRTXexited-55,100-$21.6M
BSXexited-183,200-$17.9M
ARGXreduced-13,612-$11.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001937964-26-000002, largest first. % of portfolio is the value over $622,424,285, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 52,939 shares; 2024Q4: 167,939 shares; 2025Q1: 318,239 shares; 2025Q2: 752,712 shares; 2025Q3: 732,212 shares; 2025Q4: 682,212 shares 682,212$119M19.08%-50,000Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 225,453 shares; 2025Q4: 600,747 shares 600,747$81M13.02%+375,294Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,138 shares; 2024Q4: 11,311 shares; 2025Q1: 11,311 shares; 2025Q2: 78,311 shares; 2025Q3: 78,311 shares; 2025Q4: 64,699 shares 64,699$54.4M8.74%-13,612Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 92,593 shares; 2024Q4: not reported; 2025Q1: 94,887 shares; 2025Q2: 30,700 shares; 2025Q3: 28,700 shares; 2025Q4: 50,500 shares 50,500$54.3M8.72%+21,800Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 532,879 shares; 2024Q4: 90,279 shares; 2025Q1: 90,279 shares; 2025Q2: 96,479 shares; 2025Q3: 146,179 shares; 2025Q4: 719,365 shares 719,365$25.3M4.07%+573,186Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,311,840 shares; 2025Q3: 1,999,702 shares; 2025Q4: 2,013,602 shares 2,013,602$25.2M4.05%+13,900Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 274,424 shares; 2024Q4: 494,424 shares; 2025Q1: 498,473 shares; 2025Q2: 494,424 shares; 2025Q3: 672,176 shares; 2025Q4: 533,698 shares 533,698$24.7M3.97%-138,478Timeline
UGLPROSHARES TR IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 537,372 shares; 2025Q4: 442,119 shares 442,119$24.5M3.94%-95,253Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 658,839 shares; 2025Q4: 1,023,539 shares 1,023,539$24.5M3.94%+364,700Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 54,285 shares; 2024Q4: 54,285 shares; 2025Q1: not reported; 2025Q2: 27,319 shares; 2025Q3: 194,838 shares; 2025Q4: 503,936 shares 503,936$17.7M2.84%+309,098Timeline
AZNASTRAZENECA PLC-SPONS ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 190,752 shares; 2024Q4: 190,752 shares; 2025Q1: 190,752 shares; 2025Q2: 190,752 shares; 2025Q3: 190,752 shares; 2025Q4: 190,752 shares 190,752$17.5M2.82%0Timeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,824 shares 70,824$15.6M2.51%newTimeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 156,300 shares; 2024Q4: 216,700 shares; 2025Q1: 316,700 shares; 2025Q2: 316,700 shares; 2025Q3: 628,367 shares; 2025Q4: 767,098 shares 767,098$14M2.25%+138,731Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,479 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,176 shares; 2025Q4: 144,376 shares 144,376$11.4M1.84%+84,200Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 108,723 shares; 2025Q4: 205,090 shares 205,090$8.45M1.36%+96,367Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 95,885 shares; 2024Q4: 284,190 shares; 2025Q1: 104,190 shares; 2025Q2: 104,190 shares; 2025Q3: 104,190 shares; 2025Q4: 104,190 shares 104,190$8.3M1.33%0Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 56,717 shares; 2025Q2: 81,717 shares; 2025Q3: 81,717 shares; 2025Q4: 40,817 shares 40,817$7.08M1.14%-40,900Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 56,400 shares; 2025Q1: 28,600 shares; 2025Q2: 20,970 shares; 2025Q3: 34,570 shares; 2025Q4: 17,400 shares 17,400$6.92M1.11%-17,170Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 695,982 shares 695,982$6.28M1.01%newTimeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 59,200 shares 59,200$6.2M1%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 41,100 shares; 2025Q3: 56,600 shares; 2025Q4: 137,800 shares 137,800$5M0.8%+81,200Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 119,741 shares 119,741$4.93M0.79%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,992,367 shares 1,992,367$4.68M0.75%newTimeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,600 shares; 2025Q3: 110,100 shares; 2025Q4: 60,100 shares 60,100$4.34M0.7%-50,000Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 172,185 shares; 2025Q2: 126,285 shares; 2025Q3: 96,285 shares; 2025Q4: 96,285 shares 96,285$4.24M0.68%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 64,608 shares; 2025Q4: 138,508 shares 138,508$4.2M0.68%+73,900Timeline
PROKPROKIDNEY CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,838,411 shares 1,838,411$4.12M0.66%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,440 shares; 2024Q4: 7,440 shares; 2025Q1: 7,440 shares; 2025Q2: 12,240 shares; 2025Q3: 12,240 shares; 2025Q4: 17,740 shares 17,740$3.78M0.61%+5,500Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,500 shares; 2025Q3: 14,500 shares; 2025Q4: 14,500 shares 14,500$3.31M0.53%0Timeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,989 shares 17,989$2.88M0.46%newTimeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 129,800 shares 129,800$2.82M0.45%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 30,900 shares; 2025Q2: 30,900 shares; 2025Q3: 30,900 shares; 2025Q4: 70,700 shares 70,700$2.7M0.43%+39,800Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 33,407 shares 33,407$2.61M0.42%newTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: 5,000 shares; 2025Q3: 5,000 shares; 2025Q4: 5,000 shares 5,000$2.44M0.39%0Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 124,440 shares; 2024Q4: 293,851 shares; 2025Q1: 333,851 shares; 2025Q2: 22,951 shares; 2025Q3: 22,951 shares; 2025Q4: 22,951 shares 22,951$2M0.32%0Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 68,653 shares 68,653$1.86M0.3%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,000 shares; 2024Q4: 40,000 shares; 2025Q1: 40,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 40,000 shares 40,000$1.79M0.29%0Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 141,061 shares; 2025Q4: 141,061 shares 141,061$1.71M0.28%0Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,400 shares; 2025Q4: 20,400 shares 20,400$1.56M0.25%0Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,600 shares; 2025Q4: 41,600 shares 41,600$1.56M0.25%0Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 205,324 shares 205,324$1.34M0.21%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 12,900 shares 12,900$1.29M0.21%newTimeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 29,200 shares; 2025Q3: 29,200 shares; 2025Q4: 29,200 shares 29,200$1.2M0.19%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,437 shares; 2024Q4: 204,045 shares; 2025Q1: 90,745 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,100 shares 8,100$815K0.13%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,570 shares 41,570$755K0.12%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,500 shares 2,500$737K0.12%newTimeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 29,192 shares 29,192$520K0.08%newTimeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 42,080 shares 42,080$513K0.08%newTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,019 shares 17,019$476K0.08%newTimeline
LYRALYRA THERAPEUTICS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,756 shares 8,756$27K<0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
INSMINSMED INC Stockput420,000$73.1Mnew
UGLPROSHARES TR II ULTRA GOLDput100,000$5.55Mnew
SLNOSOLENO THERAPEUTICS INC COMcall50,000$2.31Mnew
ABVXABIVAX SA SPONSORED ADScall9,900$1.34Mnew
OCULOCULAR THERAPEUTIX INC COMcall85,200$1.03Mnew

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
INSMINSMED INC400,000$57.6Mcall
VERONA PHARMA PLCVERONA PHARMA PLC379,004$40.4Mshares
MERUS N VMERUS N V296,750$27.9Mshares
VRTXVERTEX PHARMACEUTICALS INC55,100$21.6Mshares
BSXBOSTON SCIENTIFIC CORP183,200$17.9Mshares
REGNREGENERON PHARMACEUTICALS10,671$6Mshares
RAREULTRAGENYX PHARMACEUTICAL IN150,000$4.51Mcall
NKTRNEKTAR THERAPEUTICS57,999$3.3Mshares
CNTACENTESSA PHARMACEUTICALS PLC133,291$3.23Mshares
TGTXTG THERAPEUTICS INC54,515$1.97Mshares
RAREULTRAGENYX PHARMACEUTICAL IN64,502$1.94Mshares
IRENIREN LIMITED33,200$1.56Mshares
BHVNBIOHAVEN LTD80,000$1.2Mshares
MREOMEREO BIOPHARMA GROUP PLC475,361$979Kshares
SRPTSAREPTA THERAPEUTICS INC44,900$865Kshares
MRNAMODERNA INC23,800$615Kshares
KALVKALVISTA PHARMACEUTICALS INC41,555$506Kshares
ATYRATYR PHARMA INC600,000$433Kcall
ATYRATYR PHARMA INC372,276$269Kshares
ALECALECTOR INC71,029$210Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001937964-26-000002 base2026-02-17acceptance time not in the bulk data set